Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design

Urea derivatives are ubiquitously found in many chemical disciplines. N,N′-substituted ureas may show different conformational preferences depending on their substitution pattern. The high energetic barrier for isomerization of the cis and trans state poses additional challenges on computational simulation techniques aiming at a reproduction of the biological properties of urea derivatives. Herein, we investigate energetics of urea conformations and their interconversion using a broad spectrum of methodologies ranging from data mining, via quantum chemistry to molecular dynamics simulation and free energy calculations. We find that the inversion of urea conformations is inherently slow and beyond the time scale of typical simulation protocols. Therefore, extra care needs to be taken by computational chemists to work with appropriate model systems. We find that both knowledge-driven approaches as well as physics-based methods may guide molecular modelers towards accurate starting structures for expensive calculations to ensure that conformations of urea derivatives are modeled as adequately as possible.

[1]  Julian E. Fuchs,et al.  Matched molecular pair analysis: significance and the impact of experimental uncertainty. , 2014, Journal of medicinal chemistry.

[2]  Thomas Fox,et al.  Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..

[3]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[4]  R. Dror,et al.  Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.

[5]  S. LaPlante,et al.  The challenge of atropisomerism in drug discovery. , 2009, Angewandte Chemie.

[6]  R. Abagyan,et al.  Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states. , 2008, Journal of medicinal chemistry.

[7]  J. Baell,et al.  Benzoylureas as removable cis amide inducers: synthesis of cyclic amides via ring closing metathesis (RCM). , 2011, Organic & biomolecular chemistry.

[8]  P. Labute proteins STRUCTURE O FUNCTION O BIOINFORMATICS Protonate3D: Assignment of ionization , 2013 .

[9]  Guojin Zhang,et al.  Raman microspectroscopic and dynamic vapor sorption characterization of hydration in collagen and dermal tissue. , 2011, Biopolymers.

[10]  A. McDermott,et al.  Cis-trans energetics in urea and acetamide studied by deuterium NMR , 1993 .

[11]  Matthias Rarey,et al.  Torsion angle preferences in druglike chemical space: a comprehensive guide. , 2013, Journal of medicinal chemistry.

[12]  A. Aubry,et al.  Unexpected stability of the urea cis-trans isomer in urea-containing model pseudopeptides. , 2001, Organic letters.

[13]  B. Kuhn,et al.  Intramolecular hydrogen bonding in medicinal chemistry. , 2010, Journal of medicinal chemistry.

[14]  Bradley D. Smith,et al.  NMR studies of hydrogen bonding interactions with secondary amide and urea groups , 2001 .

[15]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[16]  E. Moir,et al.  N,N'-diarylureas: a new family of atropisomers exhibiting highly diastereoselective reactivity. , 2008, The Journal of organic chemistry.

[17]  O. Hucke,et al.  Assessing atropisomer axial chirality in drug discovery and development. , 2011, Journal of medicinal chemistry.

[18]  A. Jabs,et al.  Non-proline cis peptide bonds in proteins. , 1999, Journal of molecular biology.

[19]  S. Sheriff,et al.  Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties. , 2015, Bioorganic & medicinal chemistry letters.

[20]  S. Pickett,et al.  Insights into the impact of N- and O-methylation on aqueous solubility and lipophilicity using matched molecular pair analysis , 2015 .

[21]  Qiang Sui,et al.  Kinetics and equilibria of cis/trans isomerization of backbone amide bonds in peptoids. , 2007, Journal of the American Chemical Society.

[22]  David A. Case,et al.  Soft‐core potentials in thermodynamic integration: Comparing one‐ and two‐step transformations , 2011, J. Comput. Chem..

[23]  M. Zhou,et al.  Crystal structure of a bacterial homologue of the kidney urea transporter , 2009, Nature.

[24]  T. Dudev,et al.  N–H stretching frequencies and the conformation of substituted ureas: an ab initio MO study , 1997 .

[25]  P. A. Harris,et al.  Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. , 2007, Journal of medicinal chemistry.

[26]  M. Germann,et al.  Characterization of secondary amide peptide bond isomerization: thermodynamics and kinetics from 2D NMR spectroscopy. , 2011, Biopolymers.

[27]  Jozef Hritz,et al.  Calculations of binding affinity between C8-substituted GTP analogs and the bacterial cell-division protein FtsZ , 2010, European Biophysics Journal.

[28]  Chris Oostenbrink,et al.  Improved ligand-protein binding affinity predictions using multiple binding modes. , 2010, Biophysical journal.

[29]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[30]  M. Marahiel,et al.  Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts , 1999, Cellular and Molecular Life Sciences CMLS.

[31]  M. Burghammer,et al.  Crystal structure analysis of free and substrate-bound 6-hydroxy-L-nicotine oxidase from Arthrobacter nicotinovorans. , 2010, Journal of molecular biology.

[32]  J. Madwed,et al.  Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. , 2002, Journal of medicinal chemistry.

[33]  N. Meanwell Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.

[34]  M. Vincent,et al.  The origin of the conformational preference of N,N'-diaryl-N,N'-dimethyl ureas. , 2010, Physical chemistry chemical physics : PCCP.

[35]  Zhiqin Ji,et al.  Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[36]  Daniel J. Warner,et al.  Matched molecular pairs as a medicinal chemistry tool. , 2011, Journal of medicinal chemistry.

[37]  George Papadatos,et al.  ChEMBL web services: streamlining access to drug discovery data and utilities , 2015, Nucleic Acids Res..

[38]  B. Hay,et al.  Conformational analysis and rotational barriers of alkyl- and phenyl-substituted urea derivatives. , 2005, The journal of physical chemistry. A.

[39]  G. Germain,et al.  Conformation of substituted arylureas. Crystal structures of N,N'-dimethyl-N,N'-di(p-nitrophenyl)urea and N,N'-dimethyl-N,N'-di(2,4-dinitrophenyl)urea , 1976 .

[40]  G. Scuseria,et al.  Gaussian 03, Revision E.01. , 2007 .

[41]  H. Kagechika,et al.  Unusual conformational preference of an aromatic secondary urea: solvent-dependent open-closed conformational switching of N,N'-bis(porphyrinyl)urea. , 2013, Chemical communications.

[42]  Christian Kramer,et al.  Strong Nonadditivity as a Key Structure–Activity Relationship Feature: Distinguishing Structural Changes from Assay Artifacts , 2015, J. Chem. Inf. Model..

[43]  Jameed Hussain,et al.  Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..

[44]  Duncan Poole,et al.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. , 2013, Journal of chemical theory and computation.

[45]  Klaus R. Liedl,et al.  A challenging system: Free energy prediction for factor Xa , 2011, J. Comput. Chem..

[46]  Robin Taylor,et al.  New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.

[47]  Julian E. Fuchs,et al.  Independent Metrics for Protein Backbone and Side-Chain Flexibility: Time Scales and Effects of Ligand Binding. , 2015, Journal of chemical theory and computation.

[48]  Jan Jadżyn,et al.  Molecular structure of hydrogen bonded N,N′-diethylurea in non-polar solvents , 1987 .

[49]  Araz Jakalian,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .

[50]  J. Clayden,et al.  The urea renaissance. , 2011, Angewandte Chemie.

[51]  Thierry Langer,et al.  The Protein Data Bank (PDB), its related services and software tools as key components for in silico guided drug discovery. , 2008, Journal of medicinal chemistry.

[52]  Christian Laurence,et al.  The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists. , 2009, Journal of medicinal chemistry.

[53]  Anthony Nicholls,et al.  Essential considerations for using protein-ligand structures in drug discovery. , 2012, Drug discovery today.

[54]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[55]  G. Labesse,et al.  Combining 'dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. , 2015, Acta crystallographica. Section D, Biological crystallography.

[56]  Glen Eugene Kellogg,et al.  Web application for studying the free energy of binding and protonation states of protein–ligand complexes based on HINT , 2009, J. Comput. Aided Mol. Des..

[57]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[58]  Martin Stahl,et al.  Small Molecule Conformational Preferences Derived from Crystal Structure Data. A Medicinal Chemistry Focused Analysis , 2008, J. Chem. Inf. Model..

[59]  A. Jabs,et al.  Peptide bonds revisited , 1998, Nature Structural &Molecular Biology.

[60]  William L Jorgensen,et al.  Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.